[GetPortalCommentsPageByObjectIdResponse(id=2188434, encodeId=18f02188434b6, content=有参考价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:38:18 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2188433, encodeId=8a47218843335, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:37:51 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=904801, encodeId=883190480168, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d85441320, createdName=ZXYY-KJ, createdTime=Fri Dec 04 11:21:17 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890802, encodeId=ac8489080239, content=很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c525424337, createdName=ms4000000657790849, createdTime=Fri Oct 09 16:02:16 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155492, encodeId=9557155492ef, content=基本明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Sun Nov 13 15:55:13 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152232, encodeId=d23b152232ba, content=有参考價值！, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/08/18cc28251093b78c00a4dabafc73bb9a.jpg, createdBy=6cff1969792, createdName=huaer9300, createdTime=Sun Oct 30 18:19:03 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379456, encodeId=155913e945607, content=#循证医学#, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449706, encodeId=bcf21449e0695, content=#循证#, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=)]
2024-02-21
cqwenli94
来自重庆
有参考价值
69
0
举报
[GetPortalCommentsPageByObjectIdResponse(id=2188434, encodeId=18f02188434b6, content=有参考价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:38:18 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2188433, encodeId=8a47218843335, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:37:51 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=904801, encodeId=883190480168, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d85441320, createdName=ZXYY-KJ, createdTime=Fri Dec 04 11:21:17 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890802, encodeId=ac8489080239, content=很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c525424337, createdName=ms4000000657790849, createdTime=Fri Oct 09 16:02:16 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155492, encodeId=9557155492ef, content=基本明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Sun Nov 13 15:55:13 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152232, encodeId=d23b152232ba, content=有参考價值！, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/08/18cc28251093b78c00a4dabafc73bb9a.jpg, createdBy=6cff1969792, createdName=huaer9300, createdTime=Sun Oct 30 18:19:03 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379456, encodeId=155913e945607, content=#循证医学#, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449706, encodeId=bcf21449e0695, content=#循证#, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=)]
2024-02-21
cqwenli94
来自重庆
希望可以阅读全文
76
0
举报
[GetPortalCommentsPageByObjectIdResponse(id=2188434, encodeId=18f02188434b6, content=有参考价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:38:18 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2188433, encodeId=8a47218843335, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:37:51 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=904801, encodeId=883190480168, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d85441320, createdName=ZXYY-KJ, createdTime=Fri Dec 04 11:21:17 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890802, encodeId=ac8489080239, content=很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c525424337, createdName=ms4000000657790849, createdTime=Fri Oct 09 16:02:16 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155492, encodeId=9557155492ef, content=基本明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Sun Nov 13 15:55:13 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152232, encodeId=d23b152232ba, content=有参考價值！, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/08/18cc28251093b78c00a4dabafc73bb9a.jpg, createdBy=6cff1969792, createdName=huaer9300, createdTime=Sun Oct 30 18:19:03 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379456, encodeId=155913e945607, content=#循证医学#, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449706, encodeId=bcf21449e0695, content=#循证#, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=)]
2020-12-04
ZXYY-KJ
希望可以阅读全文
0
0
举报
[GetPortalCommentsPageByObjectIdResponse(id=2188434, encodeId=18f02188434b6, content=有参考价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:38:18 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2188433, encodeId=8a47218843335, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:37:51 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=904801, encodeId=883190480168, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d85441320, createdName=ZXYY-KJ, createdTime=Fri Dec 04 11:21:17 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890802, encodeId=ac8489080239, content=很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c525424337, createdName=ms4000000657790849, createdTime=Fri Oct 09 16:02:16 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155492, encodeId=9557155492ef, content=基本明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Sun Nov 13 15:55:13 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152232, encodeId=d23b152232ba, content=有参考價值！, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/08/18cc28251093b78c00a4dabafc73bb9a.jpg, createdBy=6cff1969792, createdName=huaer9300, createdTime=Sun Oct 30 18:19:03 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379456, encodeId=155913e945607, content=#循证医学#, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449706, encodeId=bcf21449e0695, content=#循证#, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=)]
2020-10-09
ms4000000657790849
很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。
129
0
举报
[GetPortalCommentsPageByObjectIdResponse(id=2188434, encodeId=18f02188434b6, content=有参考价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:38:18 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2188433, encodeId=8a47218843335, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:37:51 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=904801, encodeId=883190480168, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d85441320, createdName=ZXYY-KJ, createdTime=Fri Dec 04 11:21:17 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890802, encodeId=ac8489080239, content=很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c525424337, createdName=ms4000000657790849, createdTime=Fri Oct 09 16:02:16 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155492, encodeId=9557155492ef, content=基本明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Sun Nov 13 15:55:13 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152232, encodeId=d23b152232ba, content=有参考價值！, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/08/18cc28251093b78c00a4dabafc73bb9a.jpg, createdBy=6cff1969792, createdName=huaer9300, createdTime=Sun Oct 30 18:19:03 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379456, encodeId=155913e945607, content=#循证医学#, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449706, encodeId=bcf21449e0695, content=#循证#, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=)]
2016-11-13
gospel007
基本明白。
128
0
举报
[GetPortalCommentsPageByObjectIdResponse(id=2188434, encodeId=18f02188434b6, content=有参考价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:38:18 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2188433, encodeId=8a47218843335, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:37:51 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=904801, encodeId=883190480168, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d85441320, createdName=ZXYY-KJ, createdTime=Fri Dec 04 11:21:17 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890802, encodeId=ac8489080239, content=很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c525424337, createdName=ms4000000657790849, createdTime=Fri Oct 09 16:02:16 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155492, encodeId=9557155492ef, content=基本明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Sun Nov 13 15:55:13 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152232, encodeId=d23b152232ba, content=有参考價值！, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/08/18cc28251093b78c00a4dabafc73bb9a.jpg, createdBy=6cff1969792, createdName=huaer9300, createdTime=Sun Oct 30 18:19:03 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379456, encodeId=155913e945607, content=#循证医学#, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449706, encodeId=bcf21449e0695, content=#循证#, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=)]
2016-10-30
huaer9300
有参考價值！
141
0
举报
[GetPortalCommentsPageByObjectIdResponse(id=2188434, encodeId=18f02188434b6, content=有参考价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:38:18 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2188433, encodeId=8a47218843335, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:37:51 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=904801, encodeId=883190480168, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d85441320, createdName=ZXYY-KJ, createdTime=Fri Dec 04 11:21:17 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890802, encodeId=ac8489080239, content=很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c525424337, createdName=ms4000000657790849, createdTime=Fri Oct 09 16:02:16 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155492, encodeId=9557155492ef, content=基本明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Sun Nov 13 15:55:13 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152232, encodeId=d23b152232ba, content=有参考價值！, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/08/18cc28251093b78c00a4dabafc73bb9a.jpg, createdBy=6cff1969792, createdName=huaer9300, createdTime=Sun Oct 30 18:19:03 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379456, encodeId=155913e945607, content=#循证医学#, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449706, encodeId=bcf21449e0695, content=#循证#, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=)]
2016-10-28
xsm918
#循证医学#
110
0
举报
[GetPortalCommentsPageByObjectIdResponse(id=2188434, encodeId=18f02188434b6, content=有参考价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:38:18 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2188433, encodeId=8a47218843335, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67691637619, createdName=cqwenli94, createdTime=Wed Feb 21 08:37:51 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=904801, encodeId=883190480168, content=希望可以阅读全文, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d85441320, createdName=ZXYY-KJ, createdTime=Fri Dec 04 11:21:17 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890802, encodeId=ac8489080239, content=很有价值，如果能贴出参考文献就好了。
贴一篇我知道的参考文献（表1，表2的出处）——《如何正确理解及使用GRADE系统》曾宪涛等。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c525424337, createdName=ms4000000657790849, createdTime=Fri Oct 09 16:02:16 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155492, encodeId=9557155492ef, content=基本明白。, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Sun Nov 13 15:55:13 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152232, encodeId=d23b152232ba, content=有参考價值！, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/08/18cc28251093b78c00a4dabafc73bb9a.jpg, createdBy=6cff1969792, createdName=huaer9300, createdTime=Sun Oct 30 18:19:03 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379456, encodeId=155913e945607, content=#循证医学#, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449706, encodeId=bcf21449e0695, content=#循证#, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Oct 28 08:00:00 CST 2016, time=2016-10-28, status=1, ipAttribution=)]
2016-10-28
xjy04
#循证#
89
0
举报